Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18602 | 478 | 39.7 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IKAROS | Author keyword | 72 | 61% | 16% | 76 |
2 | AIOLOS | Author keyword | 29 | 75% | 4% | 21 |
3 | BCL11B | Author keyword | 27 | 71% | 5% | 22 |
4 | ALLELIC LOSS OR LOH ANALYSIS | Author keyword | 8 | 100% | 1% | 5 |
5 | IKAROS FAMILY | Author keyword | 6 | 80% | 1% | 4 |
6 | GAMMA RAY INDUCED THYMIC LYMPHOMA | Author keyword | 6 | 100% | 1% | 4 |
7 | MOUSE THYMIC LYMPHOMAS | Author keyword | 6 | 100% | 1% | 4 |
8 | BCL11B GENE | Author keyword | 3 | 100% | 1% | 3 |
9 | THYMIC LYMPHOMA | Author keyword | 3 | 18% | 3% | 14 |
10 | CTIP1 | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IKAROS | 72 | 61% | 16% | 76 | Search IKAROS | Search IKAROS |
2 | AIOLOS | 29 | 75% | 4% | 21 | Search AIOLOS | Search AIOLOS |
3 | BCL11B | 27 | 71% | 5% | 22 | Search BCL11B | Search BCL11B |
4 | ALLELIC LOSS OR LOH ANALYSIS | 8 | 100% | 1% | 5 | Search ALLELIC+LOSS+OR+LOH+ANALYSIS | Search ALLELIC+LOSS+OR+LOH+ANALYSIS |
5 | IKAROS FAMILY | 6 | 80% | 1% | 4 | Search IKAROS+FAMILY | Search IKAROS+FAMILY |
6 | GAMMA RAY INDUCED THYMIC LYMPHOMA | 6 | 100% | 1% | 4 | Search GAMMA+RAY+INDUCED+THYMIC+LYMPHOMA | Search GAMMA+RAY+INDUCED+THYMIC+LYMPHOMA |
7 | MOUSE THYMIC LYMPHOMAS | 6 | 100% | 1% | 4 | Search MOUSE+THYMIC+LYMPHOMAS | Search MOUSE+THYMIC+LYMPHOMAS |
8 | BCL11B GENE | 3 | 100% | 1% | 3 | Search BCL11B+GENE | Search BCL11B+GENE |
9 | THYMIC LYMPHOMA | 3 | 18% | 3% | 14 | Search THYMIC+LYMPHOMA | Search THYMIC+LYMPHOMA |
10 | CTIP1 | 2 | 67% | 0% | 2 | Search CTIP1 | Search CTIP1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIOLOS | 33 | 74% | 5% | 25 |
2 | TRANSCRIPTION FACTOR IKAROS | 24 | 82% | 3% | 14 |
3 | SPLIT DOSE IRRADIATION | 23 | 86% | 3% | 12 |
4 | TRANSCRIPTION FACTOR BCL11B | 19 | 74% | 3% | 14 |
5 | IKAROS GENE | 14 | 34% | 7% | 33 |
6 | B 10 MICE | 11 | 78% | 1% | 7 |
7 | MOUSE THYMIC LYMPHOMAS | 10 | 50% | 3% | 14 |
8 | PRELYMPHOMA CELLS | 9 | 64% | 2% | 9 |
9 | RADIATION INDUCED LYMPHOMAS | 8 | 100% | 1% | 5 |
10 | MURINE THYMIC LYMPHOMAS | 6 | 80% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ikaros and leukaemia | 2015 | 1 | 87 | 39% |
The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity | 2011 | 35 | 100 | 54% |
Ikaros, aiolos and helios: Transcription regulators and lymphoid malignancies | 2003 | 60 | 40 | 88% |
Haematopoietic cell-fate decisions, chromatin regulation and ikaros | 2002 | 200 | 92 | 29% |
The emerging role of the lkaros stem cell factor in the neuroendocrine system | 2008 | 5 | 30 | 80% |
Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - The role of Ikaros | 2014 | 1 | 47 | 62% |
Role of the transcription factor Bcl11b in development and lymphomagenesis | 2012 | 7 | 93 | 46% |
The Multifaceted Roles of Bcl11b in Thymic and Peripheral T Cells: Impact on Immune Diseases | 2014 | 3 | 60 | 35% |
Ikaros in immune receptor signaling, lymphocyte differentiation, and function | 2010 | 28 | 74 | 35% |
Ikaros-family proteins: In search of molecular functions during lymphocyte development | 2005 | 25 | 78 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYST IMMUNOBIOL | 2 | 43% | 0.6% | 3 |
2 | LOW DOSE RADIAT EXPT CARCINOGENESIS | 1 | 100% | 0.4% | 2 |
3 | MRCCLIN SCI LYMPHOCYTE DEV GRP | 1 | 100% | 0.4% | 2 |
4 | PROT INTERACT SIGNALING | 1 | 100% | 0.4% | 2 |
5 | EPIGENET TUMORIGENESIS | 1 | 40% | 0.4% | 2 |
6 | RECH CANCEROL EXPT | 1 | 40% | 0.4% | 2 |
7 | FREEMAN ENDOCRINE ONCOL | 1 | 17% | 1.0% | 5 |
8 | EA7292 | 1 | 33% | 0.4% | 2 |
9 | LOW DOSE RADIAT EFFECT PROJECT | 1 | 33% | 0.4% | 2 |
10 | ARTS SCI COMP | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176436 | PAX5//EXPT HEMATOPOIESIS UNIT//EBF |
2 | 0.0000123137 | PU1//SPI 1 PU1//SFPI1 PU1 |
3 | 0.0000119175 | TEL AML1//LEUKAEMIA CYTOGENET GRP//ETV6 |
4 | 0.0000074683 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
5 | 0.0000061413 | ALKALINE PHOSPHATE ACTIVITY//IN VIVO SENSITIZATION//SYNTHETIC LIPID |
6 | 0.0000059582 | PERSISTENT VIRAL DIS//FRIEND VIRUS//MOMULV TS1 |
7 | 0.0000058677 | T CELL DEVELOPMENT//PRE T CELL RECEPTOR//THYMIC SELECTION |
8 | 0.0000055889 | VDJ RECOMBINATION//RAG2//RAG1 |
9 | 0.0000054005 | BIOCHEM KITA KU//INTERLEUKIN L0//KOMPETENZZENTRUM MED TIROL |
10 | 0.0000052761 | HA RAS//MIHALY PEKAR MED LIFE SCI LIB//HISTOL PATHOL ANAT SECT |